ArriVent BioPharma, Inc. Sees Notable Rise in Short Interest
Dec 15, 2024
Biopharma Invest Advisor
Connect Biopharma Releases Encouraging Long-Term Results for Rademikibart in Atopic Dermatitis Study
Nov 22, 2023